...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of women’s health >Epidemiology of fertility treatment use among U.S. women with liveborn infants, 1997-2004.
【24h】

Epidemiology of fertility treatment use among U.S. women with liveborn infants, 1997-2004.

机译：1997年至2004年，美国有活产婴儿的妇女进行生育治疗的流行病学。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

OBJECTIVE: This study assessed reported use of assisted reproductive technology (ART) and other (non-ART) fertility treatments among a population-based sample and examined factors related to use. METHODS: The data for this study were collected as part of the National Birth Defects Prevention Study (NBDPS), limited to women from the control group who delivered liveborn infants with no major birth defects. We described prevalence of the use of ART and clomiphene citrate (the most commonly used non-ART treatment) by demographic and lifestyle factors and examined associations among use of fertility treatments and pregnancy outcomes, timing of prenatal care initiation, and use of prenatal testing technologies. RESULTS: Overall, 4.2% of women reported any type of maternal fertility treatment use; 1.0% reported ART use, 1.6% reported clomiphene citrate use without ART, and 1.7% reported other fertility treatments. Women who reported any fertility treatment type were more likely than women with an unassisted conception to be non-Hispanic white, >30 years of age, and more highly educated. Overall, women who reported ART use were more likely than women who reported unassisted pregnancy to have an amniocentesis; however, this association was no longer evident after adjustment for maternal age. CONCLUSIONS: Fertility treatment use and type of treatment vary by maternal characteristics. This information may be useful to inform a broad maternal and child health audience about the growing use of fertility treatments, including who is using the treatments and the choices they are making about prenatal care.
机译：目的：本研究评估了基于人群的样本中报告的辅助生殖技术（ART）和其他（非ART）生育治疗的使用，并检查了与使用有关的因素。方法：本研究的数据是作为全国出生缺陷预防研究（NBDPS）的一部分而收集的，仅限于对照组的妇女，这些妇女分娩的婴儿没有严重的出生缺陷。我们通过人口统计学和生活方式因素描述了ART和柠檬酸克罗米芬（最常用的非ART治疗）的使用率，并研究了生育治疗和妊娠结局，开始产前护理的时间以及使用产前检测技术之间的关联。结果：总体上，有4.2％的妇女报告了使用任何类型的孕产妇治疗方法; 1.0％的患者报告使用ART，1.6％的患者报告未使用ART的柠檬酸克罗米酚，1.7％的患者报告其他生育治疗。报告任何生育治疗类型的女性比未受孕的女性更有可能是非西班牙裔白人，> 30岁且受过高等教育。总体而言，报告使用抗逆转录病毒疗法的妇女比报告无辅助妊娠的妇女更容易进行羊膜穿刺术。但是，在调整了产妇年龄之后，这种联系不再明显。结论：生育治疗的使用和治疗类型因母体特征而异。该信息可能有助于使广大母婴健康人群了解生育治疗的日益普及，包括谁在使用生育治疗以及他们对产前保健的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号